Capital Flow Monitor · Sponsors · CIK 1882991

Alphina Therapeutics, Inc.

55 Church Street, New Haven, CT, 06510 · (650) 438-8738

Biotechnology · Corporation· inc. DELAWARE true

Fit score

Offering

$10.0M

Sold

$154K

% sold

1.5%

Investors

3

Min investment

$0

Exemption

506(b)

Filing history

FiledFormRuleOfferingSold% soldInvestors
2026-03-16 D ·current 506(b) $10.0M $154K 1.5% 3 EDGAR ↗

Related persons

Executive officers, directors and promoters, as filed.

  • Nicholas J Galli — Executive Officer / Director, New Haven, CT
  • Ranjit Bindra — Director, New Haven, CT
  • Kevin Rakin — Director, New Haven, CT
  • Colleen Cuffaro — Director, Westport, CT
  • Barbara Fox — Executive Officer / Director, New Haven, CT
  • Matthew Cohen — Director, Bala Cynwyd, PA

Placement agents

  • No sales compensation reported — direct raise.

Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.